Alba A. Brandes

Istituto delle Scienze Neurologiche di Bologna — Italy

Medicine · Health Sciences

84h-index62.3kcitations648works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(463), Brain Metastases and Treatment(193), Radiomics and Machine Learning in Medical Imaging(89), Cancer, Hypoxia, and Metabolism(61), Meningioma and schwannoma management(52)

Publications640 total

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial
Journal of Neuro-Oncology·2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis
The Oncologist·2026Open Access
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
The Lancet Oncology·2025Open Access
Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Table S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S7 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Table S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
BIOM-09. PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA
Neuro-Oncology·2025· 1 citedOpen Access
QOL-26. Health-Related Quality of Life in Molecular Glioma Subtypes: A Pooled Analysis from 16 Randomized Trials
Neuro-Oncology·2025Open Access
OS04.2.A FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.
Neuro-Oncology·2025Open Access
OS01.7.A AGE AND SEX AS RISK FACTORS FOR HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN GLIOMA PATIENTS: POOLED ANALYSES OF CLINICAL TRIALS FROM THE CODAGLIO 2.0 DATABASE
Neuro-Oncology·2025Open Access
Emerging strategies and advances in the management of sinonasal carcinoma
Expert Review of Anticancer Therapy·2025
Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.
Journal of Clinical Oncology·2025· 1 cited
CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY
Neuro-Oncology·2024· 2 citedOpen Access
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Acta Neuropathologica·2024· 14 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Martin J. van den Bent(24), Thierry Gorlia(18), Roger Stupp(17), Michael Weller(16), Wolfgang Wick(13), Enrico Franceschi(11), Warren Mason(10), Martin Taphoorn(9), Johan M. Kros(9), Monika E. Hegi(8), Alicia Tosoni(8), Anouk Allgeier(7), Denis Lacombe(7), Olivier Chinot(7), Mario Ermani(7), David A. Reardon(6), Denis Lacombe(6), James Perry(6), Paul M. Clément(6), Charles J. Vecht(5)